Patient-inclusion in clinical trial design recording

Ella Balasa and Dr. Andreas Reimann hosted a live discussion on Patient inclusion in clinical trial design – why it matters and how you can get started See more

Ella Balasa and Dr. Andreas Reimann hosted a live discussion on Patient inclusion in clinical trial design – why it matters and how you can get started on Monday, 12 Sept. using LinkedIn Live.

Topics included:
1
Patient inclusion in clinical trial design –
– At what stage in the development process should patient perspectives be considered?
– What are the mutual benefits to both patients and industry to collaborate in trial design?
– What are current barriers industry faces in bringing greater patient involvement into trial design and how to remedy them?
– How to assure patients will feel valued as collaborators in trial development?

2 Patient inclusion in clinical trial design – why it matters for industry

3 Q&A

Watch the recording

Related news

15. Sep 2022

Co-creating digital health applications and digital therapeutics (DTx)

Why it matters to obtain patient insights along the digital health app and DTx development journey

20. May 2020

How companies can contact patients and patient organizations in a compliant and mutually beneficial way

After evaluating and identifying the right patient representatives and assessing the regulatory framework conditions some companies may still struggle with a question that may sound simple but can be really tricky when it comes to acting: How to approach a patient or a patient organization in the best way?

31. May 2017

Patient Engagement as a key to making Drug Development more successful and efficient

Nancy Meyerson-Hess about the benefits of patient engagement in R&D in the latest ClinicalTrialsArena article. Nancy Meyerson-Hess, BA, MPhil, discusses the benefits of patient engagement in R&D Patient engagement, a strong term, but what does it really mean?